Citations

Mayo Clinic

Showing 10 of 108522 citations.

Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma
Paul, Barry , Raza, Shahzad , Mammadzadeh, Aytaj , Khasawneh, B. , Shatnawi, Sara, Ahmed, Nausheen , Mushtaq, Muhammad Umair , Atrash, Shebli , Raza, Shahzad , Khasawneh, Bayan , Ahmed, Nausheen , Atrash, Shebli , Paul, Barry , Anwer, Faiz , McGuirk, Joseph P. , Mahmoudjafari, Zahra , Abdallah, Al-Ola

Cancers | August 23, 2024 | Volume: 16 | Issue: 17 | Pages: 2938

10.3390/cancers16172938 | PMID 39272795 Get It

The use of 4-drug induction regimens for treatment naïve newly diagnosed multiple myeloma (NDMM) is associated with improved depth of response and progression-free survival (PFS). However, head-to-head trials of 4-drug combinations are lacking, and instead, these regimens are typically compared to 3-drug backbones; limiting the ability to discern whether any additional benefit (or toxicity) is simply additive or represents a synergy (or interaction). We conducted a meta-analysis of phase 2 and phase 3 clinical trials that randomized treatment naïve NDMM patients to either a 4-drug or 3-drug induction regimen. We included 11 trials which represented 6509 unique patients. PFS for all trials in the meta-analysis was 54 months with a 4-drug induction and 8.9 months with a 3-drug induction (HR: 0.49; 95% CI: 0.45; 0.54), but there was no benefit to using a 4-drug induction that did not include an anti-CD38 antibody (PFS 4-drug 8.1 months, PFS 3-drug 8.0 months; HR 0.95; 95% CI 0.86; 1.06). Adverse events were more frequent with the quadruplet regimens but were predominately mild. High-grade (≥3) adverse events (AEs) that were more common with 4-drug regimens were infections (RR: 1.34; 95% CI 1.17; 1.54) and thrombocytopenia (RR: 1.39; 95% CI 1.12; 1.74). This study suggests that 4-drug induction regimens which include an anti-CD38 antibody improve efficacy although with additional toxicity in NDMM patients.
Utilizing Generalized Linear Mixed Effects Models for Prediction of Bone Mineral Decrease After Lung Transplant – A Preliminary Study
Sebro, Ronnie , Elmahdy, Mahmoud

Studies in Health Technology and Informatics | August 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti240778 | PMID 39176838 Get It

Introduction: Recipients of lung transplants are at heightened risk of developing low bone mineral density (BMD). They also have increased risk of developing osteoporosis-related fractures. This rate of BMD decline is not well characterized. The aim of this manuscript is to characterize the rate of BMD decrease after lung transplant. Methodology: This is a preliminary retrospective cohort study of 200 patients who received lung transplants. Each patient had pre-transplant dual energy X-ray absorptiometry (DXA) and post-transplant DXA scans on the same DXA scanner. The BMD at each lumbar vertebra, total hip, and femoral neck were recorded. Generalized linear mixed effects models with random intercepts and random slopes were used to model the rate of change of BMD after transplant, adjusting for time since transplant, sex, and sex*time interaction. Results: We found that men had higher baseline BMD than women at all sites (P<0.05 for all). The rate of BMD decrease was fastest at the femoral neck (P<0.05). Men lost BMD at a faster rate (-5.23 x10-5 g/cm2/day) than women at the femoral neck (-2.22 x10-5 g/cm2 /day). Conclusion: BMD decreases after lung transplant and occurs faster in men than women.
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
Chauhan, Pradeep S. , Alahi, Irfan , Sinha, Savar , Ledet, Elisa M. , Mueller, Ryan , Linford, Jessica , Shiang, Alexander L. , Webster, Jace , Greiner, Lilli , Yang, Breanna , Ni, Gabris , Dang, Ha X. , Saha, Debanjan , Babbra, Ramandeep K. , Feng, Wenjia , Qaium, Faridi , Alexander, Steven , Miller, Patrick J. , Caputo, Sydney , Orme, Jacob J. , Tang, Chad , Maher, Christopher A. , Chaudhuri, Aadel A. , Harris, Peter K , Duose, Dzifa Y , Alexander, Sanchez E , Sherry, Alexander D , Jaeger, Ellen B , Miller, Patrick J , Caputo, Sydney A , Orme, Jacob J , Lucien, Fabrice , Park, Sean S , Tang, Chad , Pachynski, Russell K , Sartor, A Oliver , Maher, Christopher A , Chaudhuri, Aadel A , Ledet, Elisa , Chauhan, Pradeep S , Sherry, Alexander D. , Jaeger, Ellen , Lucien, Fabrice , Park, Sean S. , Pachynski, Russell K. , Sartor, Oliver

Clinical Cancer Research | August 23, 2024 | Volume: 31 | Issue: 1 | Pages: 151-163

10.1158/1078-0432.ccr-24-1658 | PMID 39177583 Get It

Abstract Purpose: Metastatic castration-resistant prostate cancer (mCRPC) resistant to androgen receptor signaling inhibitors (ARSI) is often lethal. Liquid biopsy biomarkers for this deadly form of disease remain under investigation, and underpinning mechanisms remain ill-understood. Experimental Design: We applied targeted cell-free DNA (cfDNA) sequencing to 126 patients with mCRPC from three academic cancer centers and separately performed genome-wide cfDNA methylation sequencing on 43 plasma samples collected prior to the initiation of first-line ARSI treatment. To analyze the genome-wide sequencing data, we performed nucleosome positioning and differential methylated region analysis. We additionally analyzed single-cell and bulk RNA sequencing data from 14 and 80 patients with mCRPC, respectively, to develop and validate a stem-like signature, which we inferred from cfDNA. Results: Targeted cfDNA sequencing detected AR/enhancer alterations prior to first-line ARSIs that correlated with significantly worse progression-free survival (P = 0.01; HR = 2.12) and overall survival (P = 0.02; HR = 2.48). Plasma methylome analysis revealed that AR/enhancer lethal mCRPC patients have significantly higher promoter-level hypomethylation than AR/enhancer wild-type mCRPC patients (P &lt; 0.0001). Moreover, gene ontology and CytoTRACE analysis of nucleosomally more accessible transcription factors in cfDNA revealed enrichment for stemness-associated transcription factors in patients with lethal mCRPC. The resulting stemness signature was then validated in a completely held-out cohort of 80 patients with mCRPC profiled by tumor RNA sequencing. Conclusions: We analyzed a total of 220 patients with mCRPC, validated the importance of cell-free AR/enhancer alterations as a prognostic biomarker in lethal mCRPC, and showed that the underlying mechanism for lethality involves reprogramming developmental states toward increased stemness. See related commentary by Nawfal et al., p. 7
Why genetic testing is important in patients with developmental disabilities—a unique case of progressive hypertonia and chorea: VARS2‐related disorder
Strader, Shannon , Peña, Loren D.M. , Huxol, Heather, Harris, Corrie , Harris, Corrie , Strader, Shannon R , Vawter‐Lee, Marissa

PM&R | August 23, 2024 | Volume: 17 | Issue: 3 | Pages: 344-346

10.1002/pmrj.13267 | PMID 39177074 Get It

Sustainability in Participatory Health: Applying WHO’s Operational Framework
Petersen, Carolyn , López–Campos, Guillermo , Petersen, Carolyn

Studies in Health Technology and Informatics | August 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti240718 | PMID 39176506 Get It

The World Health Organization’s Operational Framework for Climate Resilient and Low Carbon Health Systems outlines 10 broad components for the development and maintenance of health systems that respond effectively to climate-related challenges. This work analyses the WHO framework from a participatory health informatics perspective and identifies specific initiatives involving non-professionals that align with the framework. Citizen and patient participation in the development of climate-resilient health systems is not only possible but also necessary to maximize climate resiliency at the community and global levels.
Opportunistic Screening for Osteoporosis Using Hand Radiographs – A Feature Augmentation Study Technique (FAST)
Mohammadi, Farid Ghareh , Sebro, Ronnie

Studies in Health Technology and Informatics | August 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti240411 | PMID 39176740 Get It

Patients with low bone mineral density (BMD) face an increased risk of fractures, yet are frequently undiagnosed. Consequently, it is imperative to have opportunistically screen for low BMD in patients undergoing other medical evaluations. This retrospective study encompassed 422 patients aged ≥ 50 who underwent both dual-energy X-ray absorptiometry (DXA) and hand radiographs (modality of digital X-ray) from three different vendors within a 12-month period. The dataset was randomly divided into training/validation (n=338) and test (n=84) datasets. we sought to predict osteoporosis/osteopenia and establish correlations between bone textural analysis and DXA measurements. Our results demonstrate that the deep learning model achieved an accuracy of 77.38%, sensitivity of 77.38%, specificity of 73.63%, and an area under the curve (AUC) of 83% in detecting osteoporosis/osteopenia. These findings suggest that hand radiographs can serve as a viable screening tool for identifying individuals warranting formal DXA assessment for osteoporosis/osteopenia.
Development of a Digital Platform to Support Child Mental Health Care
Rainosek, Erin , Whiteside, Stephen P. H. , Gloe, Lilianne M. , Biggs, Bridget K.

Studies in Health Technology and Informatics | August 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti240334 | PMID 39176663 Get It

Childhood mental health problems are a leading cause of disability and frequently go untreated. Barriers to children receiving the most effective care available include shortfalls in three areas: identification, referral to specialists, and delivery of evidence-based treatment (EBT). The current paper details an effort to develop a digital health intervention, the Mental Health Advisor (MHA), to increase the number of children with mental health problems who receive optimal care through identification, specialty referral, and fidelity to EBT. We present this pilot as a case example to help guide other efforts to improve mental health care through technology.
Neuropsychology practice guidance for the neuropsychiatric aspects of Long COVID
Considine, Ciaran , Becker, Jacqueline , Hoskinson, Kristen R. , Ng, Rowena , Vargas, Gray, Puente, Antonio Enrique, Lippa, Sara M. , Whiteside, Douglas M. , Koterba, Christine H , Becker, Jacqueline H , Ng, Rowena , Basso, Michael R. , Whiteside, Douglas , Puente, Antonio E.

The Clinical Neuropsychologist | August 23, 2024 | Volume: 39 | Issue: 4 | Pages: 870-898

10.1080/13854046.2024.2392943 | PMID 39177216 Get It

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
Chiang, Chia‐Chun , Schwedt, Todd J. , Dumkrieger, Gina , Chao, Chieh‐Ju , Ouellette, Heather A., Chen, Yi‐Chieh , Burke, Krista M., Wang, Han , Murray, Ann , Montenegro, Monique M. , Stern, Jennifer I. , Whealy, Mark , Cutrer, F. Michael , Chao, Chieh-Ju , Jones, Brandon M, Wang, Han , Murray, Ann M, Cutrer, Fred M, Chiang, Chia-Chun , Schwedt, Todd J , Dumkrieger, Gina , Wang, Liguo , Banerjee, Imon , Jones, Brandon M., Kissoon, Narayan

Headache: The Journal of Head and Face Pain | August 23, 2024 | Volume: 64 | Issue: 9 | Pages: 1094-1108

10.1111/head.14806 | PMID 39176658 Get It

Abstract Objective To develop machine learning models using patient and migraine features that can predict treatment responses to commonly used migraine preventive medications. Background Currently, there is no accurate way to predict response to migraine preventive medications, and the standard trial‐and‐error approach is inefficient. Methods In this cohort study, we analyzed data from the Mayo Clinic Headache database prospectively collected from 2001 to December 2023. Adult patients with migraine completed questionnaires during their initial headache consultation to record detailed clinical features and then at each follow‐up to track preventive medication changes and monthly headache days. We included patients treated with at least one of the following migraine preventive medications: topiramate, beta‐blockers (propranolol, metoprolol, atenolol, nadolol, timolol), tricyclic antidepressants (amitriptyline, nortriptyline), verapamil, gabapentin, onabotulinumtoxinA, and calcitonin gene‐related peptide (CGRP) monoclonal antibodies (mAbs) (erenumab, fremanezumab, galcanezumab, eptinezumab). We pre‐trained a deep neural network, “TabNet,” using 145 variables, then employed TabNet‐embedded data to construct prediction models for each medication to predict binary outcomes (responder vs. non‐responder). A treatment responder was defined as having at least a 30% reduction in monthly headache days from baseline. All model performances were evaluated, and metrics were reported in the held‐out test set (train 85%, test 15%). SHapley Additive exPlanations (SHAP) were conducted to determine variable importance. Results Our final analysis included 4260 patients. The responder rate for each medication ranged from 28.7% to 34.9%, and the mean time to treatment outcome for each medication ranged from 151.3 to 209.5 days. The CGRP mAb prediction model achieved a high area under the receiver operating characteristics curve (AUC) of 0.825 (95% confidence interval [CI] 0.726, 0.920) and an accuracy of 0.80 (95% CI 0.70, 0.88). The AUCs of prediction models for beta‐blockers, tricyclic antidepressants, topiramate, verapamil, gabapentin, and onabotulinumtoxinA were: 0.664 (95% CI 0.579, 0.745), 0.611 (95% CI 0.562, 0.682), 0.605 (95% CI 0.520, 0.688), 0.673 (95% CI 0.569, 0.724), 0.628 (0.533, 0.661), and 0.581 (95% CI 0.550, 0.632), respectively. Baseline monthly headache days, age, body mass index (BMI), duration of migraine attacks, responses to previous medication trials, cranial autonomic symptoms, family history of headache, and migraine attack triggers were among the most important variables across all models. A variable could have different contributions; for example, lower BMI predicts responsiveness to CGRP mAbs and beta‐blockers, while higher BMI predicts responsiveness to onabotulinumtoxinA, topiramate, and gabapentin. Conclusion We developed an accurate prediction model for CGRP mAbs treatment response, leveraging detailed migraine features gathered from a headache questionnaire before starting treatment. Employing the same methods, the model performances for other medications were less impressive, though similar to the machine learning models reported in the literature for other diseases. This may be due to CGRP mAbs being migraine‐specific. Incorporating medical comorbidities, genomic, and imaging factors might enhance the model performance. We demonstrated that migraine characteristics are important in predicting treatment responses and identified the most crucial predictors for each of the seven types of preventive medications. Our results suggest that precision migraine treatment is feasible.
Microvascular remodeling after autologous stem cell transplant in an overlap of systemic sclerosis and systemic lupus erythematosus: A case report
Mumtaz, Sehreen , Balistreri, Lisa , Abril, Andy , Ayala, Ernesto, Butendieck, Ronald R., Berianu, Florentina , Balistreri, Lisa M, Mumtaz, Sehreen

SAGE Open Medical Case Reports | August 23, 2024 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/2050313x241271811 | PMID 39185071 Get It

Microvascular remodeling and capillary repopulation can occur after autologous hematopoietic stem cell transplant (HSCT) in patients with systemic sclerosis and systemic lupus erythematosus (SLE). We aim to report evidence for microvascular remodeling after autologous HSCT as observed by nailfold videocapillaroscopy (NVC). We describe a rare occurrence of features consistent with systemic sclerosis and SLE in a 33-year-old female with a complex clinical course refractory to conventional treatments, ultimately requiring autologous HSCT. We performed NVC before and after HSCT using optical video and light microscopy. At the microvascular level, morphologic changes in the capillary vascular bed were observed after HSCT. Pretransplant damage in capillary structure was noted as evidenced on NVC with architectural loss, ramifications, capillary drop, and decreased density. Posttransplant NVC revealed an increase in capillary density with evidence of microvascular remodeling. Further studies on the clinical use and impact of microvascular remodeling on disease progression are needed and looking into the application of NVC scoring to assess clinical response would be meaningful.